FDA won't ban breast implants linked to cancer for now

The FDA will not ban the sale and use of textured breast implants linked to a rare cancer, despite recent concerns over the safety of the product.

The implants have been associated with anaplastic large-cell lymphoma, a rare cancer of the immune system. A majority of the cases occurred in women with textured implants manufactured by Allergan. Many other countries have banned the use of textured implants.

However, the FDA said May 2 that there was not enough evidence to justify banning the implants.

"At this time, the FDA does not believe that, on the basis of all available data and information, the device meets the banning standard set forth in the federal Food, Drug and Cosmetic Act," the FDA said.

More articles on supply chain:
Free 1-day Prime shipping coming soon, Amazon says
A generic version of Narcan, a device for ADHD & more: 6 recent FDA approvals
How the US healthcare system can tackle its sustainability problem

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers